REPORTS

Let’s Pullulate and Expand Your Business

Global RNA-interference (RNAi) Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Dec 01, 2019  |  165 PAGES  |  REPORT CODE: CMM256217
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The RNA-interference (RNAi) is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. The research provides insights for the global RNA-interference (RNAi) market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the RNA-interference (RNAi) industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global RNA-interference (RNAi) Market Segmentations:

By Players:

  • ISIS Pharmaceuticals

  • Quark Pharmaceuticals Inc.

  • Tekmira Pharmaceuticals Corporation

  • Qiagen NV

  • Alnylam Pharmaceuticals

  • Arrowhead

  • Phio Pharmaceuticals Corp.

  • Merck & Co. Inc. (Sigma Aldrich)

  • Thermo Fisher Scientific Inc.

  • Arcturus Therapeutics

  • Ionis Pharmaceuticals Inc.

  • RXI Pharmaceuticals

  • Silence Therapeutics PLC

  • Benitec Biopharma Ltd

  • Dicerna Pharmaceuticals

By Types:

  • Chemical synthesis

  • In vitro transcription

  • In vivo expression

By End-User:

  • Drug Discovery and Development

  • Therapeutics

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of RNA-interference (RNAi) Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global RNA-interference (RNAi) Market Share by Types

    • 1.3.2 Global RNA-interference (RNAi) Market Size and Growth Rate of Chemical synthesis from 2014 to 2026

    • 1.3.3 Global RNA-interference (RNAi) Market Size and Growth Rate of In vitro transcription from 2014 to 2026

    • 1.3.4 Global RNA-interference (RNAi) Market Size and Growth Rate of In vivo expression from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global RNA-interference (RNAi) Market Share by End-Users

    • 1.4.2 Global RNA-interference (RNAi) Market Size and Growth Rate of Drug Discovery and Development from 2014 to 2026

    • 1.4.3 Global RNA-interference (RNAi) Market Size and Growth Rate of Therapeutics from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina RNA-interference (RNAi) Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of RNA-interference (RNAi) Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of RNA-interference (RNAi) by Major Types

    • 3.4.1 Market Size and Growth Rate of Chemical synthesis

    • 3.4.2 Market Size and Growth Rate of In vitro transcription

    • 3.4.3 Market Size and Growth Rate of In vivo expression

4 Segmentation of RNA-interference (RNAi) Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of RNA-interference (RNAi) by Major End-Users

    • 4.4.1 Market Size and Growth Rate of RNA-interference (RNAi) for Drug Discovery and Development

    • 4.4.2 Market Size and Growth Rate of RNA-interference (RNAi) for Therapeutics

5 Market Analysis by Major Regions

  • 5.1 Global RNA-interference (RNAi) Production Analysis by Major Regions

  • 5.2 Global RNA-interference (RNAi) Consumption Analysis by Major Regions

  • 5.3 Global RNA-interference (RNAi) Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America RNA-interference (RNAi) Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe RNA-interference (RNAi) Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific RNA-interference (RNAi) Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa RNA-interference (RNAi) Production, Import, Consumption and Export Analysis

6 Product Commodity of RNA-interference (RNAi) Market in Major Countries

  • 6.1 Top 5 Export Countries in RNA-interference (RNAi) market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in RNA-interference (RNAi) market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in RNA-interference (RNAi) market from 2014 to 2019

  • 6.2 Top 5 Import Countries in RNA-interference (RNAi) market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in RNA-interference (RNAi) market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in RNA-interference (RNAi) market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America RNA-interference (RNAi) Landscape Analysis

  • 7.1 North America RNA-interference (RNAi) Landscape Analysis by Major Types

  • 7.2 North America RNA-interference (RNAi) Landscape Analysis by Major End-Users

  • 7.3 North America RNA-interference (RNAi) Landscape Analysis by Major Countries

    • 7.3.1 United States RNA-interference (RNAi) Market Volume and Growth Rate

    • 7.3.2 Canada RNA-interference (RNAi) Market Volume and Growth Rate

    • 7.3.3 Mexico RNA-interference (RNAi) Market Volume and Growth Rate

8 Europe RNA-interference (RNAi) Landscape Analysis

  • 8.1 Europe RNA-interference (RNAi) Landscape Analysis by Major Types

  • 8.2 Europe RNA-interference (RNAi) Landscape Analysis by Major End-Users

  • 8.3 Europe RNA-interference (RNAi) Landscape Analysis by Major Countries

    • 8.3.1 Germany RNA-interference (RNAi) Market Volume and Growth Rate

    • 8.3.2 UK RNA-interference (RNAi) Market Volume and Growth Rate

    • 8.3.3 France RNA-interference (RNAi) Market Volume and Growth Rate

    • 8.3.4 Italy RNA-interference (RNAi) Market Volume and Growth Rate

    • 8.3.5 Nordic Countries RNA-interference (RNAi) Market Volume and Growth Rate

    • 8.3.6 Spain RNA-interference (RNAi) Market Volume and Growth Rate

    • 8.3.7 Belgium RNA-interference (RNAi) Market Volume and Growth Rate

    • 8.3.8 Poland RNA-interference (RNAi) Market Volume and Growth Rate

    • 8.3.9 Russia RNA-interference (RNAi) Market Volume and Growth Rate

    • 8.3.10 Turkey RNA-interference (RNAi) Market Volume and Growth Rate

9 Asia Pacific RNA-interference (RNAi) Landscape Analysis

  • 9.1 Asia Pacific RNA-interference (RNAi) Landscape Analysis by Major Types

  • 9.2 Asia Pacific RNA-interference (RNAi) Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific RNA-interference (RNAi) Landscape Analysis by Major Countries

    • 9.3.1 China RNA-interference (RNAi) Market Volume and Growth Rate

    • 9.3.2 Japan RNA-interference (RNAi) Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand RNA-interference (RNAi) Market Volume and Growth Rate

    • 9.3.4 India RNA-interference (RNAi) Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries RNA-interference (RNAi) Market Volume and Growth Rate

    • 9.3.6 South Korea RNA-interference (RNAi) Market Volume and Growth Rate

10 Latin America, Middle East & Africa RNA-interference (RNAi) Landscape Analysis

  • 10.1 Latin America, Middle East & Africa RNA-interference (RNAi) Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa RNA-interference (RNAi) Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa RNA-interference (RNAi) Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries RNA-interference (RNAi) Market Volume and Growth Rate

    • 10.3.2 Brazil RNA-interference (RNAi) Market Volume and Growth Rate

    • 10.3.3 Nigeria RNA-interference (RNAi) Market Volume and Growth Rate

    • 10.3.4 South Africa RNA-interference (RNAi) Market Volume and Growth Rate 

    • 10.3.5 Argentina RNA-interference (RNAi) Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 ISIS Pharmaceuticals

    • 11.1.1 ISIS Pharmaceuticals Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Quark Pharmaceuticals Inc.

    • 11.2.1 Quark Pharmaceuticals Inc. Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Tekmira Pharmaceuticals Corporation

    • 11.3.1 Tekmira Pharmaceuticals Corporation Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Qiagen NV

    • 11.4.1 Qiagen NV Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Alnylam Pharmaceuticals

    • 11.5.1 Alnylam Pharmaceuticals Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Arrowhead

    • 11.6.1 Arrowhead Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Phio Pharmaceuticals Corp.

    • 11.7.1 Phio Pharmaceuticals Corp. Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Merck & Co. Inc. (Sigma Aldrich)

    • 11.8.1 Merck & Co. Inc. (Sigma Aldrich) Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Thermo Fisher Scientific Inc.

    • 11.9.1 Thermo Fisher Scientific Inc. Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Arcturus Therapeutics

    • 11.10.1 Arcturus Therapeutics Company Profile and Development Status

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Ionis Pharmaceuticals Inc.

    • 11.11.1 Ionis Pharmaceuticals Inc. Company Profile and Development Status

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 RXI Pharmaceuticals

    • 11.12.1 RXI Pharmaceuticals Company Profile and Development Status

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Silence Therapeutics PLC

    • 11.13.1 Silence Therapeutics PLC Company Profile and Development Status

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Benitec Biopharma Ltd

    • 11.14.1 Benitec Biopharma Ltd Company Profile and Development Status

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Dicerna Pharmaceuticals

    • 11.15.1 Dicerna Pharmaceuticals Company Profile and Development Status

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 85 Figures and 159 Tables)

  • Figure Product Picture

  • Figure Global RNA-interference (RNAi) Market Size and Growth Rate of Chemical synthesis from 2014 to 2026

  • Figure Global RNA-interference (RNAi) Market Size and Growth Rate of In vitro transcription from 2014 to 2026

  • Figure Global RNA-interference (RNAi) Market Size and Growth Rate of In vivo expression from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global RNA-interference (RNAi) Market Size and Growth Rate of Drug Discovery and Development from 2014 to 2026

  • Figure Global RNA-interference (RNAi) Market Size and Growth Rate of Therapeutics from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina RNA-interference (RNAi) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of RNA-interference (RNAi) Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of RNA-interference (RNAi)

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of RNA-interference (RNAi) by Different Types from 2014 to 2026

  • Table Consumption Share of RNA-interference (RNAi) by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Chemical synthesis

  • Figure Market Size and Growth Rate of In vitro transcription

  • Figure Market Size and Growth Rate of In vivo expression

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of RNA-interference (RNAi) by Different End-Users from 2014 to 2026

  • Table Consumption Share of RNA-interference (RNAi) by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Drug Discovery and Development

  • Figure Market Size and Growth Rate of Therapeutics

  • Table Global RNA-interference (RNAi) Production by Major Regions

  • Table Global RNA-interference (RNAi) Production Share by Major Regions

  • Figure Global RNA-interference (RNAi) Production Share by Major Regions in 2014

  • Figure Global RNA-interference (RNAi) Production Share by Major Regions in 2018

  • Figure Global RNA-interference (RNAi) Production Share by Major Regions in 2026

  • Table Global RNA-interference (RNAi) Consumption by Major Regions

  • Table Global RNA-interference (RNAi) Consumption Share by Major Regions

  • Figure Global RNA-interference (RNAi) Consumption Share by Major Regions in 2014

  • Figure Global RNA-interference (RNAi) Consumption Share by Major Regions in 2018

  • Figure Global RNA-interference (RNAi) Consumption Share by Major Regions in 2026

  • Table North America RNA-interference (RNAi) Production, Import, Consumption and Export Analysis

  • Table Europe RNA-interference (RNAi) Production, Import, Consumption and Export Analysis

  • Table Asia Pacific RNA-interference (RNAi) Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa RNA-interference (RNAi) Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in RNA-interference (RNAi) market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in RNA-interference (RNAi) market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in RNA-interference (RNAi) market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in RNA-interference (RNAi) market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America RNA-interference (RNAi) Consumption by Types from 2014 to 2026

  • Table North America RNA-interference (RNAi) Consumption Share by Types from 2014 to 2026

  • Figure North America RNA-interference (RNAi) Consumption Share by Types in 2014

  • Figure North America RNA-interference (RNAi) Consumption Share by Types in 2018

  • Figure North America RNA-interference (RNAi) Consumption Share by Types in 2026

  • Table North America RNA-interference (RNAi) Consumption by End-Users from 2014 to 2026

  • Table North America RNA-interference (RNAi) Consumption Share by End-Users from 2014 to 2026

  • Figure North America RNA-interference (RNAi) Consumption Share by End-Users in 2014

  • Figure North America RNA-interference (RNAi) Consumption Share by End-Users in 2018

  • Figure North America RNA-interference (RNAi) Consumption Share by End-Users in 2026

  • Table North America RNA-interference (RNAi) Consumption by Major Countries from 2014 to 2026

  • Table North America RNA-interference (RNAi) Consumption Share by Major Countries from 2014 to 2026

  • Figure North America RNA-interference (RNAi) Consumption Share by Major Countries in 2014

  • Figure North America RNA-interference (RNAi) Consumption Share by Major Countries in 2018

  • Figure North America RNA-interference (RNAi) Consumption Share by Major Countries in 2026

  • Figure United States RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Table Europe RNA-interference (RNAi) Consumption by Types from 2014 to 2026

  • Table Europe RNA-interference (RNAi) Consumption Share by Types from 2014 to 2026

  • Figure Europe RNA-interference (RNAi) Consumption Share by Types in 2014

  • Figure Europe RNA-interference (RNAi) Consumption Share by Types in 2018

  • Figure Europe RNA-interference (RNAi) Consumption Share by Types in 2026

  • Table Europe RNA-interference (RNAi) Consumption by End-Users from 2014 to 2026

  • Table Europe RNA-interference (RNAi) Consumption Share by End-Users from 2014 to 2026

  • Figure Europe RNA-interference (RNAi) Consumption Share by End-Users in 2014

  • Figure Europe RNA-interference (RNAi) Consumption Share by End-Users in 2018

  • Figure Europe RNA-interference (RNAi) Consumption Share by End-Users in 2026

  • Table Europe RNA-interference (RNAi) Consumption by Major Countries from 2014 to 2026

  • Table Europe RNA-interference (RNAi) Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe RNA-interference (RNAi) Consumption Share by Major Countries in 2014

  • Figure Europe RNA-interference (RNAi) Consumption Share by Major Countries in 2018

  • Figure Europe RNA-interference (RNAi) Consumption Share by Major Countries in 2026

  • Figure Germany RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure UK RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure France RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific RNA-interference (RNAi) Consumption by Types from 2014 to 2026

  • Table Asia Pacific RNA-interference (RNAi) Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific RNA-interference (RNAi) Consumption Share by Types in 2014

  • Figure Asia Pacific RNA-interference (RNAi) Consumption Share by Types in 2018

  • Figure Asia Pacific RNA-interference (RNAi) Consumption Share by Types in 2026

  • Table Asia Pacific RNA-interference (RNAi) Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific RNA-interference (RNAi) Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific RNA-interference (RNAi) Consumption Share by End-Users in 2014

  • Figure Asia Pacific RNA-interference (RNAi) Consumption Share by End-Users in 2018

  • Figure Asia Pacific RNA-interference (RNAi) Consumption Share by End-Users in 2026

  • Table Asia Pacific RNA-interference (RNAi) Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific RNA-interference (RNAi) Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific RNA-interference (RNAi) Consumption Share by Major Countries in 2014

  • Figure Asia Pacific RNA-interference (RNAi) Consumption Share by Major Countries in 2018

  • Figure Asia Pacific RNA-interference (RNAi) Consumption Share by Major Countries in 2026

  • Figure China RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandRNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure India RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa RNA-interference (RNAi) Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa RNA-interference (RNAi) Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa RNA-interference (RNAi) Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa RNA-interference (RNAi) Consumption Share by Major Countries in 2026

  • Figure GCC Countries RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina RNA-interference (RNAi) Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of ISIS Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ISIS Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of ISIS Pharmaceuticals

  • Figure Revenue and Market Share Analysis of ISIS Pharmaceuticals

  • Table Product and Service Introduction of ISIS Pharmaceuticals

  • Table Company Profile and Development Status of Quark Pharmaceuticals Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quark Pharmaceuticals Inc.

  • Figure Sales and Growth Rate Analysis of Quark Pharmaceuticals Inc.

  • Figure Revenue and Market Share Analysis of Quark Pharmaceuticals Inc.

  • Table Product and Service Introduction of Quark Pharmaceuticals Inc.

  • Table Company Profile and Development Status of Tekmira Pharmaceuticals Corporation

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tekmira Pharmaceuticals Corporation

  • Figure Sales and Growth Rate Analysis of Tekmira Pharmaceuticals Corporation

  • Figure Revenue and Market Share Analysis of Tekmira Pharmaceuticals Corporation

  • Table Product and Service Introduction of Tekmira Pharmaceuticals Corporation

  • Table Company Profile and Development Status of Qiagen NV

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen NV

  • Figure Sales and Growth Rate Analysis of Qiagen NV

  • Figure Revenue and Market Share Analysis of Qiagen NV

  • Table Product and Service Introduction of Qiagen NV

  • Table Company Profile and Development Status of Alnylam Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

  • Table Product and Service Introduction of Alnylam Pharmaceuticals

  • Table Company Profile and Development Status of Arrowhead

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead

  • Figure Sales and Growth Rate Analysis of Arrowhead

  • Figure Revenue and Market Share Analysis of Arrowhead

  • Table Product and Service Introduction of Arrowhead

  • Table Company Profile and Development Status of Phio Pharmaceuticals Corp.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Phio Pharmaceuticals Corp.

  • Figure Sales and Growth Rate Analysis of Phio Pharmaceuticals Corp.

  • Figure Revenue and Market Share Analysis of Phio Pharmaceuticals Corp.

  • Table Product and Service Introduction of Phio Pharmaceuticals Corp.

  • Table Company Profile and Development Status of Merck & Co. Inc. (Sigma Aldrich)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co. Inc. (Sigma Aldrich)

  • Figure Sales and Growth Rate Analysis of Merck & Co. Inc. (Sigma Aldrich)

  • Figure Revenue and Market Share Analysis of Merck & Co. Inc. (Sigma Aldrich)

  • Table Product and Service Introduction of Merck & Co. Inc. (Sigma Aldrich)

  • Table Company Profile and Development Status of Thermo Fisher Scientific Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific Inc.

  • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific Inc.

  • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific Inc.

  • Table Product and Service Introduction of Thermo Fisher Scientific Inc.

  • Table Company Profile and Development Status of Arcturus Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arcturus Therapeutics

  • Figure Sales and Growth Rate Analysis of Arcturus Therapeutics

  • Figure Revenue and Market Share Analysis of Arcturus Therapeutics

  • Table Product and Service Introduction of Arcturus Therapeutics

  • Table Company Profile and Development Status of Ionis Pharmaceuticals Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ionis Pharmaceuticals Inc.

  • Figure Sales and Growth Rate Analysis of Ionis Pharmaceuticals Inc.

  • Figure Revenue and Market Share Analysis of Ionis Pharmaceuticals Inc.

  • Table Product and Service Introduction of Ionis Pharmaceuticals Inc.

  • Table Company Profile and Development Status of RXI Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RXI Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of RXI Pharmaceuticals

  • Figure Revenue and Market Share Analysis of RXI Pharmaceuticals

  • Table Product and Service Introduction of RXI Pharmaceuticals

  • Table Company Profile and Development Status of Silence Therapeutics PLC

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics PLC

  • Figure Sales and Growth Rate Analysis of Silence Therapeutics PLC

  • Figure Revenue and Market Share Analysis of Silence Therapeutics PLC

  • Table Product and Service Introduction of Silence Therapeutics PLC

  • Table Company Profile and Development Status of Benitec Biopharma Ltd

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Benitec Biopharma Ltd

  • Figure Sales and Growth Rate Analysis of Benitec Biopharma Ltd

  • Figure Revenue and Market Share Analysis of Benitec Biopharma Ltd

  • Table Product and Service Introduction of Benitec Biopharma Ltd

  • Table Company Profile and Development Status of Dicerna Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Dicerna Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Dicerna Pharmaceuticals

  • Table Product and Service Introduction of Dicerna Pharmaceuticals


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top